Headquarters
Israel
Every company in the roster headquartered in Israel.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
7 of 7 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Teva Pharmaceutical IndustriesTEVA · NYSE | 13 assets: 9 approved, 3 Ph 3, 1 Ph 1 | Olanzapine (TV-44749)Phase 3 · SchizophreniaReliable signal | 15 Jan 2027Anle138b · Phase 1 |
 Neurim Pharmaceuticals Ltd.Private | 2 assets: 2 Ph 3 | Melatonin prolonged-releasePhase 3 | None on record |
 BioLineRx Ltd.BLRX · Nasdaq | 1 asset: 1 approved | Approved assets only | None on record |
 Enlivex TherapeuticsENLV · Nasdaq | 1 asset: 1 Ph 2 | AllocetraPhase 2 · Osteoarthritis | Feb 2027Allocetra · Phase 2 |
 Kahr MedicalPrivate | 1 asset: 1 Ph 2 | DSP107Phase 1/2 · Non-Small Cell Lung Cancer | None on record |
 Mapi PharmaPrivate | 1 asset: 1 Ph 2 | Cariprazine long-acting injection (Mapi Pharma)Phase 1/2 · Schizophrenia | 31 Dec 2026Cariprazine long-acting injection (Mapi Pharma) · Phase 1/2 |
 OramedORMP · Nasdaq | 1 asset: 1 Ph 3 | ORMD-0801Phase 3 · Type 2 DiabetesPartial signal | 25 Apr 2027ORMD-0801 · Phase 3 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).